These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

317 related articles for article (PubMed ID: 32985309)

  • 21. Thrombocytopenia predicts mortality in Chinese hemodialysis patients- an analysis of the China DOPPS.
    Zhao X; Niu Q; Gan L; Hou FF; Liang X; Ni Z; Chen X; Chen Y; McCullough K; Robinson B; Zuo L
    BMC Nephrol; 2022 Jan; 23(1):11. PubMed ID: 34979949
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Trimethylamine N-oxide is associated with long-term mortality risk: the multi-ethnic study of atherosclerosis.
    Wang M; Li XS; Wang Z; de Oliveira Otto MC; Lemaitre RN; Fretts A; Sotoodehnia N; Budoff M; Nemet I; DiDonato JA; Tang WHW; Psaty BM; Siscovick DS; Hazen SL; Mozaffarian D
    Eur Heart J; 2023 May; 44(18):1608-1618. PubMed ID: 36883587
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The Carnitine-butyrobetaine-trimethylamine-N-oxide pathway and its association with cardiovascular mortality in patients with carotid atherosclerosis.
    Skagen K; Trøseid M; Ueland T; Holm S; Abbas A; Gregersen I; Kummen M; Bjerkeli V; Reier-Nilsen F; Russell D; Svardal A; Karlsen TH; Aukrust P; Berge RK; Hov JE; Halvorsen B; Skjelland M
    Atherosclerosis; 2016 Apr; 247():64-9. PubMed ID: 26868510
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Trimethylamine N-oxide and cardiovascular outcomes in patients with chronic heart failure after myocardial infarction.
    Zhou X; Jin M; Liu L; Yu Z; Lu X; Zhang H
    ESC Heart Fail; 2020 Feb; 7(1):188-193. PubMed ID: 31960610
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Advanced chronic kidney disease populations have elevated trimethylamine N-oxide levels associated with increased cardiovascular events.
    Kim RB; Morse BL; Djurdjev O; Tang M; Muirhead N; Barrett B; Holmes DT; Madore F; Clase CM; Rigatto C; Levin A;
    Kidney Int; 2016 May; 89(5):1144-1152. PubMed ID: 27083288
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Association of Uremic Solutes With Cardiovascular Death in Diabetic Kidney Disease.
    Sapa H; Gutiérrez OM; Shlipak MG; Katz R; Ix JH; Sarnak MJ; Cushman M; Rhee EP; Kimmel PL; Vasan RS; Schrauben SJ; Feldman HI; Seegmiller JC; Brunengraber H; Hostetter TH; Schelling JR;
    Am J Kidney Dis; 2022 Oct; 80(4):502-512.e1. PubMed ID: 35351578
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Circulating trimethylamine N-oxide and the risk of cardiovascular diseases: a systematic review and meta-analysis of 11 prospective cohort studies.
    Qi J; You T; Li J; Pan T; Xiang L; Han Y; Zhu L
    J Cell Mol Med; 2018 Jan; 22(1):185-194. PubMed ID: 28782886
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Plasma trimethylamine N-oxide and its metabolic precursors and risk of mortality, cardiovascular and renal disease in individuals with type 2-diabetes and albuminuria.
    Winther SA; Øllgaard JC; Hansen TW; von Scholten BJ; Reinhard H; Ahluwalia TS; Wang Z; Gæde P; Parving HH; Hazen S; Pedersen O; Rossing P
    PLoS One; 2021; 16(3):e0244402. PubMed ID: 33657115
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Association Between Trimethylamine N-oxide and Adverse Kidney Outcomes and Overall Mortality in Type 2 Diabetes Mellitus.
    Yu PS; Wu PH; Hung WW; Lin MY; Zhen YY; Hung WC; Chang JM; Tsai JR; Chiu YW; Hwang SJ; Tsai YC
    J Clin Endocrinol Metab; 2024 Jul; 109(8):2097-2105. PubMed ID: 38267025
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Relationship between leptin and all-cause and cardiovascular mortality in chronic hemodialysis patients.
    Díez JJ; Bossola M; Fernández-Reyes MJ; Di Stasio E; Tazza L; Luciani G; Codoceo R; Iglesias P; Rodríguez A; González E; Selgas R
    Nefrologia; 2011; 31(2):206-12. PubMed ID: 21461015
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Associations among serum trimethylamine-N-oxide (TMAO) levels, kidney function and infarcted coronary artery number in patients undergoing cardiovascular surgery: a cross-sectional study.
    Mafune A; Iwamoto T; Tsutsumi Y; Nakashima A; Yamamoto I; Yokoyama K; Yokoo T; Urashima M
    Clin Exp Nephrol; 2016 Oct; 20(5):731-739. PubMed ID: 26676906
    [TBL] [Abstract][Full Text] [Related]  

  • 32. All-Cause Mortality and Trimethylamine N-Oxide Levels in Patients with Cardiovascular Disease.
    Konieczny R; Żurawska-Płaksej E; Kaaz K; Czapor-Irzabek H; Bombała W; Mysiak A; Kuliczkowski W
    Cardiology; 2022; 147(4):443-452. PubMed ID: 35970148
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Trimethylamine-N-oxide (TMAO) predicts short- and long-term mortality and poor neurological outcome in out-of-hospital cardiac arrest patients.
    Hochstrasser SR; Metzger K; Vincent AM; Becker C; Keller AKJ; Beck K; Perrig S; Tisljar K; Sutter R; Schuetz P; Bernasconi L; Neyer P; Marsch S; Hunziker S
    Clin Chem Lab Med; 2020 Aug; 59(2):393-402. PubMed ID: 32866111
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prognostic value of elevated levels of intestinal microbe-generated metabolite trimethylamine-N-oxide in patients with heart failure: refining the gut hypothesis.
    Tang WH; Wang Z; Fan Y; Levison B; Hazen JE; Donahue LM; Wu Y; Hazen SL
    J Am Coll Cardiol; 2014 Nov; 64(18):1908-14. PubMed ID: 25444145
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Circulating trimethylamine-N-oxide is associated with all-cause mortality in subjects with nonalcoholic fatty liver disease.
    Flores-Guerrero JL; Post A; van Dijk PR; Connelly MA; Garcia E; Navis G; Bakker SJL; Dullaart RPF
    Liver Int; 2021 Oct; 41(10):2371-2382. PubMed ID: 33993608
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Gut microbiota-dependent trimethylamine N-oxide (TMAO) pathway contributes to both development of renal insufficiency and mortality risk in chronic kidney disease.
    Tang WH; Wang Z; Kennedy DJ; Wu Y; Buffa JA; Agatisa-Boyle B; Li XS; Levison BS; Hazen SL
    Circ Res; 2015 Jan; 116(3):448-55. PubMed ID: 25599331
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Microbiota-derived Trimethylamine N-oxide Predicts Cardiovascular Risk After STEMI.
    Matsuzawa Y; Nakahashi H; Konishi M; Sato R; Kawashima C; Kikuchi S; Akiyama E; Iwahashi N; Maejima N; Okada K; Ebina T; Hibi K; Kosuge M; Ishigami T; Tamura K; Kimura K
    Sci Rep; 2019 Aug; 9(1):11647. PubMed ID: 31406181
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Loop diuretics decrease the renal elimination rate and increase the plasma levels of trimethylamine-N-oxide.
    Latkovskis G; Makarova E; Mazule M; Bondare L; Hartmane D; Cirule H; Grinberga S; Erglis A; Liepinsh E; Dambrova M
    Br J Clin Pharmacol; 2018 Nov; 84(11):2634-2644. PubMed ID: 30069897
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Trimethylamine-N-oxide (TMAO) and clinical outcomes in patients with end-stage kidney disease receiving peritoneal dialysis.
    Chang D; Xu X; Yang Z; Ma T; Nie J; Dong J
    Perit Dial Int; 2022 Nov; 42(6):622-630. PubMed ID: 34724845
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Trimethylamine N-Oxide and Risk of Cardiovascular Disease and Mortality.
    Kanitsoraphan C; Rattanawong P; Charoensri S; Senthong V
    Curr Nutr Rep; 2018 Dec; 7(4):207-213. PubMed ID: 30362023
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.